Comparison of obstetric and perinatal complications in intracytoplasmic sperm injection cycles with autologous oocytes and donated oocytes.

OBJECTIVE: The aim of this study was to compare the obstetric and perinatal complications in women who became pregnant with autologous oocytes and those who received donated oocytes (DO) in intracytoplasmic sperm injection cycles (ICSI). METHODS: A retrospective cohort study was carried out by collecting data from medical records between 2019 and 2022. Only patients who underwent ICSI in an induced cycle using their own or freshly DO, with male infertility factor and tubal factor, were included. RESULTS: A total of 120 patients were assessed, comprising 51 cases utilizing their own oocytes (control group) and 69 cases employing DO (study group). Patients receiving DO (n=69) exhibited a significantly higher mean age compared to those utilizing their own oocytes (n=51) (41.96±2.16 vs 38.54±1.42 years, p<0.001). There was no significant association between the source of oocytes and gestational age at delivery (p=0.296), birth weight (p=0.836), admission to neonatal intensive care unit (ICU) (p=0.120), or maternal admission to adult ICU (p=0.767). Additionally, the origin of oocytes did not demonstrate any significant association with the risk of pre-eclampsia (p=0.357), gestational diabetes mellitus (p=0.187), premature rupture of membranes (p=0.996), uterine atony (p=0.996), placenta previa (p=0.393), oligohydramnios (p=0.393), or gestational hypertension (p=0.393)." CONCLUSION: An increase in obstetric and perinatal complications was not observed in pregnancies with DO compared to pregnancies with autologous oocytes in women undergoing ICSI without prior comorbidities. Further studies with larger sample sizes are required to validate our findings.

Comparison of obstetric and perinatal complications in intracytoplasmic sperm injection cycles with autologous oocytes and donated oocytes

SUMMARY OBJECTIVE: The aim of this study was to compare the obstetric and perinatal complications in women who became pregnant with autologous oocytes and those who received donated oocytes (DO) in intracytoplasmic sperm injection cycles (ICSI). METHODS: A retrospective cohort study was carried out by collecting data from medical records between 2019 and 2022. Only patients who underwent ICSI in an induced cycle using their own or freshly DO, with male infertility factor and tubal factor, were included. RESULTS: A total of 120 patients were assessed, comprising 51 cases utilizing their own oocytes (control group) and 69 cases employing DO (study group). Patients receiving DO (n=69) exhibited a significantly higher mean age compared to those utilizing their own oocytes (n=51) (41.96±2.16 vs 38.54±1.42 years, p<0.001). There was no significant association between the source of oocytes and gestational age at delivery (p=0.296), birth weight (p=0.836), admission to neonatal intensive care unit (ICU) (p=0.120), or maternal admission to adult ICU (p=0.767). Additionally, the origin of oocytes did not demonstrate any significant association with the risk of pre-eclampsia (p=0.357), gestational diabetes mellitus (p=0.187), premature rupture of membranes (p=0.996), uterine atony (p=0.996), placenta previa (p=0.393), oligohydramnios (p=0.393), or gestational hypertension (p=0.393)." CONCLUSION: An increase in obstetric and perinatal complications was not observed in pregnancies with DO compared to pregnancies with autologous oocytes in women undergoing ICSI without prior comorbidities. Further studies with larger sample sizes are required to validate our findings.

Síndrome dos ovários policísticos: avaliação dopplerfluxométrica / Polycystic ovary syndrome: doppler flow measurement evaluation

Objetivo: avaliar a eficácia do Doppler colorido como método diagnóstico na síndrome dos ovários policísticos (SOP), mediante as variações do fluxo sangüíneo no estroma ovariano, nas artérias uterinas e no tecido subendometrial. Métodos: foram selecionadas trinta pacientes distribuídas em dois grupos: quinze com amenorréia ou oligomenorréia, hirsutismo (índice de Ferriman e Gallwey >8), índice de massa corporal IMC maior que 25 kg/m² e exame ecográfico que identificou estroma aumentado, hiperecogênico e policistose ovariana (grupo de estudo), e número idêntico de pacientes com ciclos menstruais normais, sem sinais de hirsutismo e ultra-sonografia normal (grupo controle). Com o uso da dopplerfluxometria transvaginal foram medidas a velocidade de pico sistólico ou velocidade máxima (V máx), índice de pulsatilidade (IP) e resistência dos vasos do estroma ovariano, da artéria uterina e do subendométrio. Resultados: a dopplervelocimetria mostrou V máx significativamente maior no estroma ovariano das pacientes com SOP (12,2 cm/s) (p<0,0004) em relação ao grupo controle (8,5cm/s). O IP da artéria uterina também se revelou muito superior no grupo com SOP (3,3 cm/s) em relação ao controle (2,7 cm/s). Outros parâmetros da dopplervelocimetria não evidenciaram diferença significativa. Ao estabelecermos um cutoff (ponto de corte) = 9 cm/s na amostragem para a V máx obtivemos os percentuais de 95,2 para sensibilidade, 80,0 para especificidade e de 83,3 para o valor preditivo positivo e 94,1 para o negativo. Com referência ao IP para um cutoff = 2,35 os testes revelaram: sensibilidade de 81,0 por cento, especificidade de 50,0 por cento, valor preditivo positivo de 63,0 por cento e negativo de 71,4 por cento. Conclusão: a dopplervelocimetria pode constituir subsídio a ser incorporado à investigação clínica e ultra-sonográfica no tocante ao diagnóstico da síndrome dos ovários policísticos.